Abvc Biopharma (ABVC) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Abvc Biopharma (ABVC) over the last 13 years, with Q3 2025 value amounting to 0.68.
- Abvc Biopharma's Equity Ratio rose 22416.62% to 0.68 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68, marking a year-over-year increase of 22416.62%. This contributed to the annual value of 0.16 for FY2024, which is 1297.21% down from last year.
- According to the latest figures from Q3 2025, Abvc Biopharma's Equity Ratio is 0.68, which was up 22416.62% from 0.58 recorded in Q2 2025.
- Over the past 5 years, Abvc Biopharma's Equity Ratio peaked at 0.7 during Q3 2021, and registered a low of 0.04 during Q2 2023.
- In the last 5 years, Abvc Biopharma's Equity Ratio had a median value of 0.34 in 2022 and averaged 0.38.
- In the last 5 years, Abvc Biopharma's Equity Ratio surged by 107405.81% in 2022 and then plummeted by 10600.92% in 2023.
- Over the past 5 years, Abvc Biopharma's Equity Ratio (Quarter) stood at 0.65 in 2021, then plummeted by 47.83% to 0.34 in 2022, then tumbled by 44.69% to 0.19 in 2023, then dropped by 12.97% to 0.16 in 2024, then soared by 320.85% to 0.68 in 2025.
- Its Equity Ratio stands at 0.68 for Q3 2025, versus 0.58 for Q2 2025 and 0.53 for Q1 2025.